[Development of new therapeutic modalities for idiopathic pulmonary fibrosis: from anti-inflammatory agents to anti-fibrosis agents].
Tatsuya
T
Okamoto
Moritaka
M
Suga
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D016207:Cytokines / Q000627:therapeutic use; D005347:Fibroblasts / Q000187:drug effects; D006801:Humans; D011658:Pulmonary Fibrosis / Q000188:drug therapy*
D020533:Angiogenesis Inhibitors; D000893:Anti-Inflammatory Agents; D016207:Cytokines